Besides, Kaplan–Meier survival analysis suggested higher SOX21-AS1 expression correlated with worse overall survival, and univariate and multivariate analyses indicated that high SOX21-AS1 expression was an independent biomarker for unfavorable overall survival in lung cancer patients [17]. This evidence concerns the gene SOX21 and lung carcinoma.